Further characterization of the role of the lipoxygenase pathway in the in vivo allograft response.
Jordan
M L
ML
Division of Urology, University of Toronto, Ontario, Canada.
Carlson
A
A
Hoffman
R A
RA
Simmons
R L
RL
D000818:Animals; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D015232:Dinoprostone / Q000096:biosynthesis; D006084:Graft Rejection / Q000187:drug effects; D007975:Leukotriene B4 / Q000096:biosynthesis; D008084:Lipoxygenase / Q000502:physiology*; D016859:Lipoxygenase Inhibitors; D009637:Masoprocol / Q000008:administration & dosage; D051379:Mice; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D011451:Prostaglandin-Endoperoxide Synthases / Q000502:physiology
D016859:Lipoxygenase Inhibitors; D007975:Leukotriene B4; D009637:Masoprocol; D008084:Lipoxygenase; D011451:Prostaglandin-Endoperoxide Synthases; D015232:Dinoprostone